Company ProfilePremium

Shenzhen Qingyi Photomask Ltd.

Company Profile Analysis

Ticker: 688138.SS深圳清溢光电股份有限公司

ESOMAR 23 Corporate BadgeISO Certifications Badge
Shenzhen Qingyi Photomask Ltd. - Semiconductor showcase

Year Founded & Workforce

1997

614 Employees

Industry

Semiconductor
Shenzhen Qingyi Photomask Ltd. logo

Shenzhen Qingyi Photomask Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Shenzhen Qingyi Photomask Ltd. Overview

Qingyi Photomask is the oldest and largest independent photomask maker in mainland China. It produces quartz and soda-lime master patterns that panel makers and chipmakers use to transfer circuit images onto glass and silicon. About four-fifths of revenue comes from flat-panel-display masks for TFT-LCD, AMOLED and LTPS lines, where Omdia ranked it fourth worldwide and first in China by 2024 sales. The rest comes mainly from semiconductor masks for power devices, foundry and advanced packaging. Here it is in volume production at 180nm, in small batches at 150nm, and in qualification at 55nm. It has plants in Shenzhen and Hefei and a RMB 3.5 billion Foshan campus that started up in late 2025. Its investment case rests on substituting imports in high-precision AMOLED, HTM and PSM masks, and on climbing the semiconductor node ladder toward 28nm. Japanese, US and Korean incumbents still dominate both markets.

What the company does. A photomask, also called a mask or reticle (掩膜版/光罩), is a high-precision plate that carries a circuit or pixel pattern. Downstream lithography tools project the pattern repeatedly onto wafers or display glass. Qingyi designs (data processing), writes (laser or electron-beam lithography), develops, etches, inspects, repairs and pellicles these masks to customer specifications. Each mask is custom, so the company works on a made-to-order basis ("以销定产"). Production is fully in-house with no outsourced processing, and the company sells directly to manufacturers. Market development combines its own sales force with agents.

Company's own description (FY2025 annual report). The company describes itself as engaged in the R&D, design, production and sale of photomasks. It calls itself one of the earliest-established and largest photomask manufacturers in China. Its products are high-precision tools that serve as the pattern "negative" in downstream manufacturing. They are classified by substrate into quartz masks and soda-lime masks. They are applied in flat-panel displays, semiconductor chips, touch panels and circuit boards. End devices include televisions, smartphones, notebooks, tablets, wearables, automotive electronics, AI hardware, network communications, home appliances, LED lighting and industrial electronics.

Revenue model. Revenue is almost entirely product sales of custom masks; there is no subscription or licensing income of note. Pricing is per mask set or per plate. Price rises steeply with substrate size (panel generation), critical-dimension (CD) tolerance, registration accuracy, layer complexity and technology type: binary, half-tone (HTM) or phase-shift (PSM). Because every new display model or chip design needs a new mask set, demand follows design starts and model refreshes as much as end-unit volumes. This gives the business partly recurring, consumable-like characteristics.

Value-chain position. The company sits between material and equipment suppliers and fab operators. Upstream, it buys quartz and soda-lime substrates and resist-coated mask blanks, mostly from Japan, invoiced in yen. It buys laser writers, e-beam writers and inspection tools, mostly imported and invoiced in US dollars. Downstream, it sells to panel makers, chip foundries, IDMs, bumping and advanced-packaging houses, touch-panel makers and PCB makers. It has begun moving upstream: Hefei Qingyi's mask-blank coating line is ramping and reduces purchased-blank costs.

Customer types and named customers (FY2024–FY2025 annual reports):

Flat-panel display: Named customers: BOE, Visionox, HKC, Tianma, CSOT (TCL Huaxing), Truly, InfoVision, Innolux, HJC (Huajiacai)

Semiconductor chips: Named customers: United Nova Technology (芯联集成), CRRC Times Electric, BYD Semiconductor, Sanan Optoelectronics, JCET, Tongfu Microelectronics, Amkor, Silan Microelectronics, Global Power Technology (泰科天润), GTA Semiconductor (积塔), Jiejie Microelectronics, StarPower, Sai MicroElectronics

Touch: Named customers: BOE, Tianma

Circuit boards: Named customers: Career Technology (紫翔电子), Avary Holding (鹏鼎控股)

Independent characterisation. Qingyi is a capital-intensive, mid-scale specialist. It is still predominantly a display-mask company: flat-panel masks were 79.5% of FY2025 main-business revenue. Its rising mix of AMOLED/LTPS masks (RMB 516 million in FY2025, up 42.75%) has driven gross-margin expansion. The semiconductor business is strategically important but small: RMB 204 million in FY2025, about 17% of revenue. Its customers are mostly 6-inch and 8-inch lines making power devices, MEMS, compound semiconductors and bumping layers, rather than leading-edge 12-inch logic. Its competitive edge comes from three things: scale and long relationships with BOE and other Chinese panel majors, plants located near panel clusters in Hefei and the Pearl River Delta, and policy tailwinds for domestic substitution. Its weaknesses are reliance on imported writers and blanks, customer concentration, and a technology gap of several node generations to Toppan, DNP, Photronics and Hoya in semiconductor masks.

Financial Narrative

All figures are in RMB under PRC Accounting Standards and come from audited annual reports (FY2022–FY2025) and unaudited interim reports for 2026. Fiscal year is the calendar year.

Income statement

FY2022 revenue growth is measured against the FY2021 base. FY2021 attributable net profit was about RMB 44.5 million, implied by the RMB 16.0 million dividend being 35.95% of profit. FY2020 revenue was about RMB 487 million.

The 2022–2025 revenue CAGR was 17.6%. Attributable net profit compounded at 23.8% over the same period.

EBITDA. The company does not report EBITDA. Using depreciation and amortisation from its statements, sell-side models put FY2025 EBITDA at about RMB 389 million (31.4% margin). Trailing EBITDA margin to mid-2026 is about 30.6%. Operating margin on a trailing basis was about 18.3% and gross margin about 31.6%.

Commentary. The FY2022–FY2024 period was a strong upswing. Display-panel capacity in China kept migrating toward AMOLED/LTPS, and Hefei capacity ramped. The semiconductor subsidiaries added capacity: cleaning tools and AOI in H1 2023 and a new writer in Q3 2023. Profit growth outpaced revenue every year from 2022 to 2024, with three consecutive years above 25%. FY2025 shows clear deceleration: revenue +11.5%, profit +8.9%. Three drags on the bottom line explain most of it. First, Shenzhen hit capacity limits. Second, Foshan pre-operating costs, interest and depreciation began to flow through, with the overhead build-up already visible from Q3 2024. Third, yen and dollar swings created foreign-exchange losses. The fall in ROE from 12.07% to 8.03% is mostly arithmetic from the April 2025 equity raise, which nearly doubled shareholders' equity.

Quarterly profile

2026 year to date.

  • H1 2026: revenue RMB 653.61 million (+5.08%); attributable net profit RMB 117.95 million (+28.16%); recurring net profit RMB 108.12 million (+30.43%); gross margin 32.64%; operating cash flow RMB 266.53 million (+75.79%). Profit growth benefited from a large swing to FX gains in financial expenses and from margin improvement.

  • 9M 2026: revenue about RMB 974 million (+4.90%); attributable net profit about RMB 160 million (+11.02%); recurring net profit about RMB 145 million (+11.55%); basic EPS RMB 0.51.

  • Q3 2026 on its own (9M less H1) shows revenue up about 5% but attributable profit down about 19% year on year. The quarter compares against an unusually strong Q3 2025 (+63.87%) and absorbs Foshan ramp costs.

Balance sheet

At 30 June 2026, total assets were RMB 4,286.43 million (+9.10% year to date) and parent equity RMB 2,868.38 million, or RMB 9.11 per share. Interest-bearing debt was about RMB 871 million and cash about RMB 621 million, giving net debt of about RMB 250 million.

At 31 March 2025, before the placement proceeds were fully deployed, fixed assets were RMB 974.2 million, construction in progress RMB 341.1 million, intangible assets (largely Foshan land use rights) RMB 80.0 million, inventories RMB 190.6 million and other equity investments RMB 13.0 million. The company has made no acquisitions, so the balance sheet carries no material goodwill. Intangibles are dominated by land use rights.

Interest-bearing liabilities were about 20% of total assets in mid-2026. The parent had RMB 412.9 million of distributable retained profit at end-2025. The 2026 bank-facility envelope is RMB 1.9 billion across the parent and five subsidiaries. A further RMB 1.5 billion of subsidiary guarantees was authorised. Approved guarantees, used plus unused, totalled RMB 1,243.6 million in April 2025, equal to 83.8% of then net assets.

Working capital (operating, as tracked by data vendors) was about RMB 291 million in FY2023, RMB 273 million in FY2024 and RMB 220 million in FY2025. It has fallen even as revenue grew, which reflects improving collection and supplier terms. Receivables still need watching. Q1 2026 receivables rose 22% from year-end, and trailing receivables were about 1.7 times net profit.

Cash flow

Operating cash generation has been excellent, and cash conversion improved every year. Free cash flow, however, turned sharply negative from 2024 because of capital spending on Foshan. The RMB 3.5 billion project began construction in March 2024, and roughly RMB 1.19 billion of the 2025 placement was allotted to it. The company funded the gap with bank borrowings in 2024 and then with placement equity in 2025. The 2024 share buyback was RMB 30.0 million, and none was carried out in 2025. Since listing, cumulative cash dividends reached about RMB 245 million by mid-2026, of which RMB 152 million came in the last three years.

Ratios

Return on invested capital. By data-vendor calculation, ROIC was about 7% in FY2025. The post-IPO median is 9.0%, and the low was 3.9% in FY2021.

Leverage. Net debt to EBITDA was under 1x at mid-2026 (about 0.6x on trailing EBITDA). Financial expenses fell 80% year on year in Q1 2026 to RMB 2.38 million as interest expense halved to RMB 4.09 million. Interest cover is therefore comfortably above 20x.

Asset turnover. Turnover has dropped to about 0.3x as Foshan assets sit on the balance sheet ahead of full revenue. This is the single biggest swing factor for future ROE.

7. Segmental and Geographic Revenue Mapping

The company's sales are concentrated on panel and chip clusters in mainland China. Its disclosure is organised by application industry and substrate, and the plant footprint offers the clearest geographic map of where value is created. Country-level revenue by customer location is not publicly disclosed. Overseas customers such as Innolux in Taiwan and Amkor account for a small share of sales.

Fastest-growing and declining areas. AMOLED/LTPS masks are the fastest-growing line: +42.75% in FY2025, served mainly from Hefei. Demand comes from BOE, Visionox and Tianma OLED lines and the new G8.6 IT-OLED fabs. Semiconductor masks have slowed from +34% in FY2024 to under +6% in FY2025 and about +1% in H1 2026. The Shenzhen Micro plant is capacity-bound, and Foshan semiconductor capacity has yet to be qualified. Soda-lime masks (PCB and touch) and the Shenzhen parent site are in structural decline.

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025

Revenue (CNY Mn)

762.15924.161,112.251,239.67

Revenue growth (%)

37.821.320.411.5

Net profit attributable to parent (CNY Mn)

99.03133.87172.01187.31

Net profit growth (%)

122.435.228.58.9

Net profit excl. non-recurring items (CNY Mn)

79.04112.61152.71167.60

Net margin, attributable (%)

13.014.515.515.1

Basic EPS (MYR Bn)

0.370.500.650.63

Diluted EPS (MYR Bn)

0.370.500.650.63

Weighted average ROE (%)

7.9810.0412.078.03

Dividend per share, full year (MYR Bn)

0.120.160.170.18

Key Financials and Margin Analysis (%)

MetricFY2023FY2024FY2025

Total profit / pre-tax income (CNY Mn)

150.65192.66213.72

Pre-tax margin (%)

16.317.317.2

Non-recurring items, net (CNY Mn)

21.2519.3019.71

Revenue History

QuarterRevenue (CNY Mn)Attributable net profit (CNY Mn)Net profit excl. non-recurring (CNY Mn)

Q1 2024

271.8249.5944.70

Q2 2024

289.0739.3236.05

Q3 2024

265.8631.5527.03

Q4 2024

285.5051.5544.94

Q1 2025

298.5451.7447.12

Q2 2025

323.4940.3035.78

Q3 2025

306.2951.7147.38

Q4 2025

311.3543.5637.33

Q1 2026

330.455.6950.7

Q2 2026

323.262.2657.4

Q3 2026 (derived)

320.441.637.1

Balance Sheet and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025

Total assets (CNY Mn)

1,743.042,076.682,742.773,928.76

Equity attributable to parent (CNY Mn)

1,281.781,383.631,483.212,778.61

Total assets less parent equity (CNY Mn)

461.26693.061,259.561,150.15

Parent equity / total assets (%)

73.566.654.170.7

Cash Flow and Financial Ratios (x)

MetricFY2022FY2023FY2024FY2025

Operating cash flow (CNY Mn)

134.94194.56305.83368.78

Operating cash flow / net profit (x)

1.361.451.781.97

Cash dividends declared for the year (CNY Mn)

32.0242.4153.2256.35

Dividend payout ratio (%)

32.331.730.930.1

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025

ROE, weighted average (%)

7.9810.0412.078.03

ROA on year-end assets (%)

5.76.46.34.8

Asset turnover on year-end assets (x)

0.440.450.410.32

R&D intensity (%)

5.875.304.895.18

Locations

SiteRegionPrimary outputFY2025 trend

Shenzhen (parent)

Pearl River Delta

Mature FPD, touch, PCB masks; FMM/HTM process development

Revenue -14.65% (capacity-limited; higher-spec work moving to Hefei)

Hefei Qingyi

Yangtze River Delta (Anhui)

G8.6 TFT, G6 AMOLED/LTPS, HTM; mask-blank coating

Revenue +22.23%

Shenzhen Qingyi Micro

Pearl River Delta

180nm/150nm semiconductor masks, bumping masks

Growing; added AOI in 2025

Foshan Qingyi

Pearl River Delta (Nanhai)

High-precision FPD masks (G8.6 and below)

Trial production late 2025; customer qualification in 2026

Foshan Qingyi Micro

Pearl River Delta (Nanhai)

High-end semiconductor masks (180nm–28nm roadmap)

Trial production; PSM volume targeted end-2026

Key Financials

SegmentH1 2025H1 2026

Flat-panel display masks (CNY Mn)

491.69528.0

Semiconductor chip masks (CNY Mn)

99.76101.0

Share Price & Returns

Reference pointPriceNote

IPO, 20 Nov 2019

8.78

IPO offer price

24 Jan 2025

27.22—

24 Apr 2025

26.67—

Apr 2025 placement

25.00

Placement price

10 Nov 2025

27.80—

23 Jan 2026

32.18—

18 Jun 2026

39.26

Market cap RMB 12.29 billion; 52-week high about RMB 40.00

8 Sep 2026

33.53—

28 Sep 2026

37.48—

29 Oct 2026

27.61

Market cap about RMB 8.69 billion

Valuation Snapshot

MultipleValueBasis

P/E (trailing)

about 42.7x

TTM attributable profit about RMB 203.6 million

P/E (2026E)

about 34x

China Post Securities 2026E net profit RMB 254 million

P/B

about 3.0x

Parent equity RMB 2.87 billion (30 Jun 2026)

EV/Sales (trailing)

about 6.95x

EV about RMB 8.94 billion; TTM revenue about RMB 1.29 billion

EV/EBITDA (FY2025)

about 23x

FY2025 EBITDA about RMB 389 million

Dividend yield

about 0.75%

RMB 0.12 interim (2026) plus RMB 0.09 final (2025)

Analyst Ratings & Targets

BrokerDateRating2026E revenue (CNY Mn)2026E net profit (CNY Mn)

China Post Securities

Jul 2026

Buy (initiation)

1,456254

Pacific Securities

Nov 2025

Buy

1,810324

Shenwan Hongyuan

Jun 2025

Outperform

1,760341

Zheshang Securities

Jun 2025

Buy

1,804313

Dividend History

YearTotal dividend (CNY Mn)Per share (MYR Bn)Payout

FY2021

16.010.0635.95%

FY2022

32.020.1232.33%

FY2023

42.410.1631.68%

FY2024

53.220.1730.9%

FY2025

56.350.1830.09%

H1 2026 interim

37.570.12

31.85% of H1 profit

Catalyst / Monitorable Details

Catalyst / monitorableExpected timingWhat to watch

55nm PSM customer qualification outcome

Q4 2026 – H1 2027

Conversion to repeat volume orders

PSM and 90nm volume production at Foshan Qingyi Micro

End-2026

Revenue contribution in the FY2026 annual report and Q1 2027

Foshan FPD utilisation and yields

H2 2026 – 2027

Gross margin holding at 32% or above despite depreciation

FY2026 results and 2026 final dividend

Apr 2027

Full-year growth versus consensus; payout of 30% or more

Completion of the trust transfer of Gwang Mo (HK)

Q4 2026

Any board recomposition or Chairman succession

G8.6 OLED line ramps at BOE and Visionox

2026–2027

Order share versus Newway

Competitive capacity (Newway Xiamen, Longtu, Guanshi)

H2 2026 onward

Price pressure in mature masks

Export-control actions on lithography equipment

Ongoing

Tool delivery and service access

Receivables and related-party sales

Quarterly

Collection trends; usage of the RMB 340 million related-party cap

Executive Leadership

Board of Directors

NamePositionBornEducationBackgroundFY2025 pay (MYR Bn)

Tang Yingmin (唐英敏)

Chairman (director since Jan 2003; Chairman since Sep 2018)

1,959

Master's

Former CFO of Cashmere House Inc. (California); director, Vice Chairman and CFO of Meadville Holdings; director and deputy MD of TTM-predecessor Hong Kong PCB operations; CFO of Gwang Mo (HK); director of Shengyi Technology; executive director of the Hefei, Foshan and Shenzhen subsidiaries. Daughter of founder Tang Hsiang-chien

1,380,000

Zhuang Dingding (庄鼎鼎)

Vice Chairman (director since May 2021; Vice Chairman since Sep 2023)

1,973

MBA, CFA, CQF

Former product development/asset management director at AEGON structured assets and MD at ING Bank (HK and Shanghai); MD-CIO of Suxi Enterprises and Wei Hua Electronics; director of Shengyi Technology

818,027

Zhang Baizhe (张百哲)

Vice Chairman

——

Non-executive vice chairman

208,000

Tang Qingnian (唐庆年)

Director

—

MBA (New York University)

Son of Tang Hsiang-chien; long-time PCB-industry executive (formerly Executive Chairman and group MD of Meadville); Justice of the Peace

108,000

Tang Jiasheng (唐嘉盛)

Director (since Nov 2022)

1,988

Bachelor's

Former research assistant on CLSA's China consumer team; INED of several insurers; director of Peninsula/Eagle entities; GP of employee-shareholding platform Shuangyi Qifei LP; director of the new trust-holding vehicle Su Sih Newco

818,027

Xie Jingyun (谢景云)

Non-executive director

——

Nominated by an external investor shareholder; takes no pay from the company

0

Jiang Wei (姜巍)

Employee-representative Director and General Manager

1,984

Bachelor's

Semiconductor mask technologist who led teams achieving first volume production of photomasks at the 10nm–28nm nodes before joining; GM since Jul 2025

1,484,357

Gao Shufeng (高术峰)

Independent director

——

Independent

108,000

Chen Jianhui (陈建惠)

Independent director

——

Independent

108,000

Wang Yi (王漪)

Independent director

——

Independent

108,000

Xu Jiansheng (许建笙)

Independent director

——

Independent

108,000

Executive Leadership Team

NameTitleBornEducationBackgroundFY2025 pay (MYR Bn)

Jiang Wei

General Manager

1,984

Bachelor's

As above

1,484,357

Ren Xinhang (任新航)

CFO (财务总裁) and Board Secretary, since Sep 2024

——

Finance lead; signs interim and annual accounts

2,116,723

Li Yuesong (李跃松)

Chief Technology Officer (技术总裁), core technical staff

1,967

Bachelor's

Joined as production deputy manager; rose through technical development, chief engineer and CTO; technology president of Shenzhen Qingyi Micro

1,072,445

Xiong Chengchun (熊成春)

Head of accounting

——

Accounting function head

—

Liu Yuan (刘元)

Securities affairs representative

——

Investor relations and disclosure

—

Board & Management Changes

DateChangeContext

May 2023

Wu Keqiang appointed GM

Long-serving CFO elevated

Sep 2023

Zhuang Dingding Vice Chairman

Family investment office executive

Sep 2024

Wu Keqiang relinquishes CFO role; Ren Xinhang becomes CFO and Board Secretary; Qin Xin steps down as Board Secretary to head Legal

Role separation ahead of the placement

17 Jul 2025

Wu Keqiang resigns as director and GM; Jiang Wei appointed GM and elected director

Brings advanced-node mask expertise for the Foshan semiconductor ramp

10 Sep 2025

Jiang Wei steps off as shareholder-elected director and is elected employee-representative director

Governance restructuring after the Supervisory Board was abolished

30 Sep 2026

Tang Yingmin and Tang Ying-nien, as executors of Tang Hsiang-chien's estate, transfer 100% of Gwang Mo (HK) (160,000,000 shares) to Su Sih Newco (BVI), then gift Newco to a Cayman private trust company (Su Sih (PTC)) as trustee of Tang Ying-nien's family trust. Both transfers are for zero consideration

Estate distribution; Tang Yingmin no longer holds any direct or indirect interest and the concert-party agreement is terminated. Tang Ying-nien becomes sole actual controller with 51.24% indirect interest. A tender-offer exemption is claimed because the controlling block is unchanged

16 Oct 2026

EGM waives the Chairman's voluntary undertaking limiting annual share sales

Precondition for the restructuring; 98.79% approval with the related shareholders abstaining

Major Shareholders

ShareholderShares% of totalType

Suxi Guangmo Technology (Shenzhen) Co., Ltd. (wholly owned by Gwang Mo HK)

86,613,60027.51

Domestic non-state legal person

Gwang Mo (Hong Kong) Limited

73,977,30023.50

Foreign legal person

Guangdong Guangxin Holdings Group Co., Ltd.

28,315,8008.99

State-owned legal person

Targets & Commitments

InitiativeDetailStatus (Oct 2026)

Foshan high-precision FPD mask base (Phase I)

G8.6-and-below high-precision FPD masks, aimed at filling China's AMOLED high-precision gap; 2,665 masks a year at Phase I capacity

Commissioned 14 Nov 2025; yield improvement and customer sampling in Q1 2026; capacity rising in H2 2026

Foshan high-end semiconductor mask base (Phase I)

180nm–28nm roadmap; e-beam writer, dry etch, domestic 28nm-capable develop/etch tools; 25,120 masks a year at Phase I capacity

Trial production; 90nm volume production targeted for 2026; PSM volume targeted end-2026; 28nm targeted 2027–2028

55nm PSM commercialisation

First PO and delivery; customer in-line qualification

Under qualification since Sep 2026

HTM capacity expansion and display PSM

Increase HTM capacity; PSM pre-research and equipment selection for display

Ongoing in FY2026

Hefei line additions

AMOLED, LTPS and Micro LED capability; HTM; new PSM capability inside existing buildings

Ongoing

Mask-blank coating (Hefei)

Upstream integration to cut material cost and localise supply

Capacity being released

Talent programme

Hired international mask-industry technical and management talent; R&D headcount up from 106 to 125 year on year

Ongoing

Subsidiary employee shareholding

RMB 54.21 million employee platform investment in Foshan Qingyi Micro (Jul 2024), plus special bonuses

Implemented

Capital raising

RMB 1.2 billion private placement (Apr 2025); RMB 1.9 billion bank facilities for 2026

Completed / in place

Shareholder returns

Interim dividends introduced (H1 2025 RMB 0.09/share; H1 2026 RMB 0.12/share); 2024 buyback of RMB 30.0 million

Ongoing

Governance

Supervisory Board abolished; revised pay policy; control consolidated in a family trust

Completed

Competitive Landscape

Market Share by Competitor

CompetitorCountry2023 FPD mask sharePositioning vs. Qingyi

Photronics (PLAB)

US (plants in Korea, Taiwan, China)

25%

Technology leader in G10.5+ and AMOLED; Chinese FPD plants in Hefei and Xiamen

SK-Electronics

Japan

20%

Large-format leader; strong in G10.5/G11

HOYA

Japan

16%

High-end FPD and blanks; vertically integrated

LG Innotek

Korea

14%

Captive-leaning supplier to LG Display; AMOLED

Shenzhen Qingyi Photomask

China

11%

Largest Chinese FPD mask maker; ranked fourth globally on 2024 sales

Newway Photomask (路维光电, 688401)

China

6%

Fast-rising domestic peer; G11 capability (number two globally in G11 in 2024 at 25.5%); main supplier to BOE Chengdu's G8.6 AMOLED line

Dai Nippon Printing (DNP)

Japan

Small in FPD

FPD and FMM metal masks

Market Share by Competitor — Toppan Photomask

CompetitorCountryMerchant share / scalePositioning

Toppan Photomask

Japan

38%

Leading-edge to 2nm-class; operates in Shanghai

Photronics

US

32%

28nm and below in Asia; JV plants in Xiamen and Hefei

DNP

Japan

14%

Leading-edge EUV masks

Taiwan Mask Corp.

Taiwan

Small

Mature-node merchant

SMIC / Huahong / CR Micro captive shops

China

Captive

Largest internal mask capacity in China

Longtu Photomask (龙图光罩, 688721)

China

Small

Power and specialty-device masks; direct domestic rival

Newway / Lux Semiconductor (路芯)

China

Small

90nm-and-above sets in supply; 40nm and 28nm single masks verified and supplied

Guanshi Technology (冠石科技)

China

Building

New 12-inch mask project

Peer Comparison FY2025

CompanyFiscal yearRevenueYoY growthNet profitNet marginR&D intensity

Shenzhen Qingyi Photomask

FY2025 (Dec)

RMB 1,239.7 M

11.5%

RMB 187.3 M

15.1%5.2%

Newway Photomask

FY2025 (Dec)

RMB 1,155 M

31.9%

RMB 252 M

21.8%

not comparable

Photronics

FY2025 (Oct)

USD 849.3 M

-2.0%

USD 136.4 M

16.1%

not comparable

Recent Developments

There were no layoffs, litigation or regulatory sanctions in the period.

Company Snapshot

$172.4M

Revenue

614

Employees

1997

Founded

SWOT Analysis

Strengths

  • Market leadership in China: ranked first in mainland China and fourth worldwide in FPD masks by 2024 sales (Omdia).
  • High-value mix: AMOLED/LTPS revenue grew from RMB 297 million (FY2023) to RMB 516 million (FY2025), lifting gross margin 1.50 points in FY2025 and to 32.64% in H1 2026.
  • Cash generation: operating cash flow of RMB 368.8 million in FY2025 was 1.97 times net profit, and rose 75.8% in H1 2026.
  • Balance-sheet capacity: parent equity rose 87% to RMB 2.78 billion after the RMB 1.19 billion net placement; net debt was about RMB 250 million at mid-2026.
  • Customer franchise: supplies BOE, Visionox, CSOT, Tianma, HKC and the G8.6 OLED line, plus about a dozen power and packaging chip customers.
  • Policy endorsement: national "Little Giant" status (2022, re-certified 2025), a provincial SOE shareholder (Guangxin, 8.99%), and co-authorship of the TFT mask industry standard.

Weaknesses

  • Slowing growth: revenue growth fell from +20.4% (FY2024) to +11.5% (FY2025) and +4.9% (9M 2026).
  • Semiconductor scale and node gap: semiconductor revenue of RMB 204 million (FY2025) grew only 5.6%. Volume production is at 180nm, behind Toppan, Photronics and DNP (≤14nm) and behind Newway's supplied 40nm/28nm single masks.
  • Imported inputs: writers and blanks are imported and invoiced in USD and JPY. The company names supplier concentration and FX losses as recurring risks.
  • Capital efficiency: asset turnover fell to 0.32x and ROE to 8.03% in FY2025; ROIC is about 7%.
  • Peer underperformance: Newway grew 31.9% in FY2025 and earned RMB 252 million against Qingyi's RMB 187 million.
  • Customer concentration: top-five customer concentration is cited as a principal risk. Three related-party panel customers alone may take up to RMB 340 million in 2026, about a quarter of sales.

Opportunities

  • Domestic share of high-precision AMOLED/LTPS masks in China is only 17.8%, leaving a large substitution runway.
  • The China semiconductor mask market is about RMB 18.7 billion, with domestic merchant penetration under 10% and about 3% at the high end.
  • Foshan Phase I adds 25,120 semiconductor masks and 2,665 high-precision FPD masks a year of capacity.
  • The 55nm PSM delivery (Sep 2026) and 90nm and PSM volume targets for 2026 open the 12-inch fab market.
  • Advanced packaging (bumping, panel-level fan-out) is already a fast-growing line.
  • Upstream blank coating in Hefei can lower material cost and reduce reliance on Japanese supply.

Threats

  • Competitive capacity build-out: Newway's RMB 2 billion Xiamen base (11 lines from H2 2026), Lux Semiconductor's 28–14nm Phase II, and Longtu and Guanshi projects.
  • Incumbents with China plants (Photronics Hefei and Xiamen; Toppan Shanghai) competing on price and technology.
  • US export controls on advanced lithography tools could limit e-beam writer and inspection-tool availability.
  • Panel-industry capex cycles and LCD maturity.
  • Depreciation from Foshan could dilute margins if utilisation lags; Q3 2026 profit fell about 19% year on year.
  • Maskless lithography is flagged by the company as a long-term substitution risk.

Key Developments

DateEventSignificance
6 May 2025Private placement results: 48.0 million shares at RMB 25.00, RMB 1.2 billion grossFunds Foshan Phase I; equity base nearly doubles
16 May 2025Board reallocates placement proceeds to the Foshan subsidiaries; up to RMB 550 million of idle proceeds approved for cash managementExecution of funded projects
26 May 20252024 AGM approves RMB 1.70 per 10 shares dividend and the placement-proceeds capital increase in Foshan Qingyi MicroShareholder returns; related-party approval
Jun 2025Sell-side initiations (Shenwan Hongyuan "Outperform"; Zheshang "Buy")Wider research coverage
17 Jul 2025GM Wu Keqiang resigns; Jiang Wei appointed GMLeadership pivot toward advanced semiconductor masks
25 Aug 2025H1 2025 results: revenue RMB 622.0 million (+10.9%); net profit RMB 92.0 million (+3.5%)Expense growth from Foshan weighs on profit
25 Aug 2025H1 2025 interim dividend of RMB 0.90 per 10 sharesFirst interim dividend
Q3 2025AOI tool added to semiconductor capacityLifts IC-mask throughput
10 Sep 2025Supervisory Board abolished; Articles amended; Jiang Wei elected employee directorGovernance modernisation
22 Oct 2025Notice that the 48.0 million placement shares become tradable on 30 Oct 2025Supply overhang
29 Oct 2025Wei Hua Electronics purchase update: 313,793 shares for RMB 8.47 million at the halfway pointFamily support for the share price
30 Oct 2025Q3 2025: revenue RMB 306.3 million (+15.2%); net profit RMB 51.7 million (+63.9%); 9M gross margin 31.48%Margin inflection
14 Nov 2025Foshan Nanhai production base commissionedCapacity milestone
28 Nov 2025Company confirms the Foshan FPD project is entering mass production; the semiconductor base is preparing for volumeExecution update
Late 2025Both Foshan projects in production-line trial operationOn schedule
25 Feb 2026Management media tour: 90nm volume production targeted for 2026, 28nm for 2027–2028; aim to be global number one in FPD masksPublic roadmap
26 Apr 2026FY2025 results: revenue RMB 1,239.7 million (+11.5%); net profit RMB 187.3 million (+8.9%); final dividend RMB 0.90 per 10 sharesGrowth slows, payout steady at 30%
26 Apr 2026Q1 2026: revenue RMB 330.4 million (+10.7%); net profit RMB 55.7 million (+7.6%); R&D +42.2%Solid start
26 Apr 20262026 "Quality, Efficiency and Shareholder Returns" action plan publishedCapital-allocation commitments
14 May 2026Company states semiconductor masks were about 17% of FY2025 revenue; PSM volume production in 2026Mix clarity
18 May 20262025 AGM: reappoints Pan-China CPA; RMB 1.9 billion facilities; RMB 340 million related-party sales capRoutine approvals
Jun 2026Shares reach a 52-week high of about RMB 40Re-rating on the semiconductor narrative
10 Jul 2026Investor site visit; Foshan Qingyi Micro Phase I "about to be put into use"Ramp-timing signal
15 Jul 2026Shares fall more than 10% intraday in a STAR Market chip sell-offSector volatility
27 Jul 2026China Post Securities initiates at "Buy" (2026E net profit RMB 254 million)Coverage
25 Aug 2026H1 2026: revenue RMB 653.6 million (+5.1%); net profit RMB 118.0 million (+28.2%); operating cash flow +75.8%; interim dividend RMB 1.20 per 10 sharesMargin-led profit growth
10 Sep 2026CITIC Securities H1 continuous-supervision report: no violations; 55nm binary verifiedClean compliance
28 Sep 202655nm PSM: PO received, delivered, customer qualification under wayTechnical milestone; shares near RMB 37.5 (market cap RMB 11.8 billion)
30 Sep 2026Control restructuring into Tang Ying-nien's family trust announced; acquisition report and simplified equity-change report filedSuccession clarity
16 Oct 2026EGM approves waiver of the Chairman's undertakingRestructuring precondition met
29 Oct 20269M 2026: revenue RMB 974 million (+4.9%); net profit RMB 160 million (+11.0%); Q3 profit about 19% lower year on yearDeceleration; shares close at RMB 27.61

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Income Statement

3 charts
Income Statement: Revenue rose from CNY 762.2 Mn in FY2022 to CNY 1,239.7 Mn in FY2025.
Shenzhen Qingyi Photomask Ltd. — Income Statement
Series (CNY Mn)FY2022FY2023FY2024FY2025
Revenue762.2924.21,112.31,239.7
Net profit attributable to parent99133.9172187.3
Net profit excl. non-recurring items79112.6152.7167.6

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.